BioNTech Dives As Second-Quarter Sales, Profit Broadly Miss ForecastsInvestors Business Daily • 08/08/22
Vaccine Targeting Fast-Spreading Omicron Subvariants Could Be Ready For Fall As Pfizer, BioNTech Announce TrialsForbes • 08/08/22
BioNTech stock sinks more than 8% after profit, revenue fall below expectationsMarket Watch • 08/08/22
BioNTech and Genmab Expand Global Strategic Collaboration to Develop and Commercialize Novel Immunotherapy CandidatesGlobeNewsWire • 08/05/22
Genmab and BioNTech Expand Global Strategic Collaboration to Develop and Commercialize Novel Immunotherapy CandidatesBusiness Wire • 08/05/22
Pfizer and BioNTech launch study to evaluate COVID-19 vaccine targeting original virus strain plus omicron variantMarket Watch • 07/27/22
Pfizer and BioNTech Advance COVID-19 Vaccine Strategy With Study Start of Next-Generation Vaccine Candidate Based on Enhanced Spike Protein DesignGlobeNewsWire • 07/27/22
BioNTech to Report Second Quarter 2022 Financial Results and Operational Update on August 8, 2022GlobeNewsWire • 07/25/22
BioNTech and Pfizer in talks to delay Covid vaccine deliveries amid EU glutProactive Investors • 07/19/22
Why 'Covid Fatigue' Isn't Enough To Keep BioNTech Down; Shares Surge On UpgradeInvestors Business Daily • 07/13/22